 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains A, B:
E.C.6.3.4.14
- Biotin carboxylase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + biotin-[carboxyl-carrier-protein] + CO2 = ADP + phosphate + carboxy-biotin-[carboxyl-carrier-protein]
|
 |
 |
 |
 |
 |
ATP
|
+
|
biotin-[carboxyl-carrier-protein]
|
+
|
CO(2)
Bound ligand (Het Group name = )
matches with 75.00% similarity
|
=
|
ADP
|
+
|
phosphate
|
+
|
carboxy-biotin-[carboxyl-carrier-protein]
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.6.4.1.2
- Acetyl-CoA carboxylase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + acetyl-CoA + HCO3- = ADP + phosphate + malonyl-CoA
|
 |
 |
 |
 |
 |
ATP
|
+
|
acetyl-CoA
|
+
|
HCO(3)(-)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
ADP
|
+
|
phosphate
|
+
|
malonyl-CoA
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Biotin
|
 |
 |
 |
 |
 |
Biotin
|
|
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
metabolic process
|
4 terms
|
 |
|
Biochemical function
|
catalytic activity
|
7 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
19:6507-6514
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery and optimization of antibacterial AccC inhibitors.
|
|
C.C.Cheng,
G.W.Shipps,
Z.Yang,
B.Sun,
N.Kawahata,
K.A.Soucy,
A.Soriano,
P.Orth,
L.Xiao,
P.Mann,
T.Black.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The biotin carboxylase (AccC) is part of the multi-component bacterial acetyl
coenzyme-A carboxylase (ACCase) and is essential for pathogen survival. We
describe herein the affinity optimization of an initial hit to give
2-(2-chlorobenzylamino)-1-(cyclohexylmethyl)-1H-benzo[d]imidazole-5-carboxamide
(1), which was identified using our proprietary Automated Ligand Identification
System (ALIS).(1) The X-ray co-crystal structure of 1 was solved and revealed
several key interactions and opportunities for further optimization in the ATP
site of AccC. Structure Based Drug Design (SBDD) and parallel synthetic
approaches resulted in a novel series of AccC inhibitors, exemplified by
(R)-2-(2-chlorobenzylamino)-1-(2,3-dihydro-1H-inden-1-yl)-1H-imidazo[4,5-b]pyridine-5-carboxamide
(40). This compound is a potent and selective inhibitor of bacterial AccC with
an IC(50) of 20 nM and a MIC of 0.8 microg/mL against a sensitized strain of
Escherichia coli (HS294 E. coli).
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.R.Novak,
D.Moldovan,
G.L.Waldrop,
and
M.S.de Queiroz
(2011).
Behavior of the ATP grasp domain of biotin carboxylase monomers and dimers studied using molecular dynamics simulations.
|
| |
Proteins, 79,
622-632.
|
 |
|
|
|
|
 |
P.J.Edwards
(2011).
The design and synthesis of libraries for the discovery of antibacterial and antifungal substances.
|
| |
Drug Discov Today, 16,
278-279.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
| |